Research Article
Changes of Tumor Markers in Patients with Breast Cancer during Postoperative Adjuvant Chemotherapy
Table 1
General characteristics of the study population (
).
| Characteristics | () | % |
| Age (years) | | | ≤57 | 45 | 50.0 | > 57 | 45 | 50.0 | Menstrual status | | | No | 56 | 62.2 | Yes | 34 | 37.8 | BMI | | | ≤24 | 40 | 44.4 | > 24 | 50 | 55.6 | Comorbidities | | | No | 51 | 56.7 | Yes | 39 | 43.3 | Tumor size | | | ≤ 2 cm | 46 | 51.1 | > 2 cm | 44 | 48.9 | Nodal status | | | 0 | 48 | 53.3 | 1-3 | 30 | 33.3 | ≥ 4 | 12 | 13.3 | HR status | | | Positive | 69 | 76.7 | Negative | 21 | 23.3 | Adjuvant chemotherapy | | | Taxane | 48 | 53.3 | Anthracycline and taxane | 42 | 46.7 | Surgery in breast | | | BCS | 35 | 38.9 | Mastectomy | 55 | 61.1 |
|
|
HR: hormone receptor; BCS = breast-conserving surgery.
|